NASDAQ:AMTX - Aemetis Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: $10.00
  • Forecasted Upside: 13.64 %
  • Number of Analysts: 1
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 1 Buy Ratings
  • 0 Strong Buy Ratings
$8.80
▲ +4.4 (100.00%)
1 month | 3 months | 12 months
Get New Aemetis Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for AMTX and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for AMTX

i We calculate consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). Our consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. Our consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
$10.00
▲ +13.64% Upside Potential
This price target is based on 1 analysts offering 12 month price targets for Aemetis in the last 3 months. The average price target is $10.00, with a high forecast of $10.00 and a low forecast of $10.00. The average price target represents a 13.64% upside from the last price of $8.80.
Buy
The current consensus among 1 contributing investment analysts is to buy stock in Aemetis. This rating has held steady since November 2019, when it changed from a Hold consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details

  • 0 strong buy ratings
  • 0 buy ratings
  • 1 hold ratings
  • 0 sell ratings
8/4/2019
  • 0 strong buy ratings
  • 0 buy ratings
  • 1 hold ratings
  • 0 sell ratings
11/2/2019
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
1/31/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
4/30/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
7/29/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
10/27/2020
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
12/26/2020
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
1/25/2021

Latest Recommendations

  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings

DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
12/3/2020HC WainwrightInitiated CoverageBuy$10.00High
i
Rating by A. Dayal at HC Wainwright
11/12/2018B. RileyReiterated RatingNeutralHigh
i
Rating by C. Driscoll at B. Riley
8/13/2018B. RileySet Price TargetHold$2.00Low
i
Rating by Carter Driscoll at B. Riley
5/14/2018B. RileySet Price TargetHold$2.00Low
i
Rating by Carter Driscoll at B. Riley
3/16/2018B. RileySet Price TargetHold$2.00High
i
Rating by Carter Driscoll at B. Riley
3/6/2018B. RileySet Price TargetHold$2.00High
i
Rating by Carter Driscoll at B. Riley
3/6/2018Ascendiant Capital MarketsInitiated CoverageBuy$2.00High
i
11/13/2017B. RileyReiterated RatingHold$2.00N/A
i
Rating by C. Driscoll at B. Riley
11/1/2017B. RileyReiterated RatingNeutralN/A
i
Rating by C. Driscoll at B. Riley
8/19/2017(FBRC)Reiterated RatingNeutral$2.00Low
i
Rating by Carter Driscoll at (FBRC)
5/16/2017(FBRC)Set Price TargetHold$2.00Low
i
Rating by Carter Driscoll at (FBRC)
11/21/2016(FBRC)Set Price TargetHold$1.75 ➝ $2.00N/A
i
Rating by carter driscoll at (FBRC)
9/8/2016(FBRC)Reiterated RatingHold$1.75N/A
i
Rating by Carter Driscoll at (FBRC)
8/16/2016(FBRC)Reiterated RatingHold$2.50N/A
i
Rating by Carter Driscoll at (FBRC)
7/25/2016(FBRC)Initiated CoverageMarket Perform$2.50N/A
i
Rating by C. Driscoll at (FBRC)
(Data available from 1/26/2016 forward)
Aemetis logo
Aemetis, Inc. operates as a renewable fuels and bio-chemicals company in North America and India. The company focuses on the acquisition, development, and commercialization of various technologies that replace traditional petroleum-based products primarily through the conversion of ethanol and biodiesel plants into advanced bio refineries. It owns and operates an ethanol facility in the California Central Valley near Modesto; and a renewable chemical and advanced fuel production facility on the East Coast of India. The company sells biodiesel and refined glycerin to transport companies, resellers, distributors, and refiners through its sales force and independent sales agents, as well as to brokers who resell the product to end-users. It also produces ethanol; and wet distiller's grains, distiller's corn oil, and condensed distillers solubles to dairies and feedlots as animal feed. In addition, it produces dairy biogas; and high-grade sanitizer alcohol and various feed products. The company was formerly known as AE Biofuels, Inc. and changed its name to Aemetis, Inc. in November 2011. Aemetis, Inc. was founded in 2005 and is headquartered in Cupertino, California.
Read More

Today's Range

Now: $8.80
$6.86
$11.00

50 Day Range

MA: $2.95
$2.25
$4.40

52 Week Range

Now: $8.80
$0.37
$11.00

Volume

60,209,436 shs

Average Volume

6,416,397 shs

Market Capitalization

$191.98 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.09

Frequently Asked Questions

What sell-side analysts currently cover shares of Aemetis?

The following sell-side analysts have issued stock ratings on Aemetis in the last year: HC Wainwright.

What is the current price target for Aemetis?

1 Wall Street analysts have set twelve-month price targets for Aemetis in the last year. Their average twelve-month price target is $10.00, suggesting a possible downside of 1.2%. HC Wainwright has the highest price target set, predicting AMTX will reach $10.00 in the next twelve months. HC Wainwright has the lowest price target set, forecasting a price of $10.00 for Aemetis in the next year.

What is the current consensus analyst rating for Aemetis?

Aemetis currently has 1 buy rating from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe AMTX will outperform the market and that investors should add to their positions of Aemetis.

What other companies compete with Aemetis?

How do I contact Aemetis' investor relations team?

Aemetis' physical mailing address is 20400 STEVENS CREEK BLVD SUITE 700, CUPERTINO CA, 95014. The specialty chemicals company's listed phone number is 408-517-3304 and its investor relations email address is [email protected] The official website for Aemetis is www.aemetis.com.